InvestorsHub Logo

isaeed

09/19/18 2:28 AM

#143058 RE: dV1 #143056

Nope, not for Vascepa.

Agenda: On both days, the committee will discuss the “Guidance for Industry: Diabetes Mellitus—Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes”